ArticleInternational journal of clinical oncology2021

Phase I study of napabucasin in combination with FOLFIRI + bevacizumab in Japanese patients with metastatic colorectal cancer.

Hiroya Taniguchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.